Among the most commonly prescribed are metformin and α-glucosidase inhibitors, which help to regulate key metabolic and inflammatory parameters such as fasting plasma glucose (FPG), fasting insulin (FINS), glycated hemoglobin (HbA1c), and homeostasis model assessment of insulin resistance (HOMA-IR). Here, INS is linked to Insulin resistance.